Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis
Sarrabeth Stone, Yuan Yue, Milos Stanojlovic, Shuangchan Wu, Gerard Karsenty, Wensheng Lin
Sarrabeth Stone, Yuan Yue, Milos Stanojlovic, Shuangchan Wu, Gerard Karsenty, Wensheng Lin
View: Text | PDF
Research Article Neuroscience

Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis

  • Text
  • PDF
Abstract

Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are chronic inflammatory demyelinating and neurodegenerative diseases of the CNS. Although neurodegeneration is the major contributor to chronic disability in MS, mechanisms governing the viability of axons and neurons in MS and EAE remain elusive. Data indicate that activation of pancreatic endoplasmic reticulum kinase (PERK) influences, positively or negatively, neuron and axon viability in various neurodegenerative diseases through induction of ATF4. In this study, we demonstrate that the PERK pathway was activated in neurons during EAE. We found that neuron-specific PERK inactivation impaired EAE resolution and exacerbated EAE-induced axon degeneration, neuron loss, and demyelination. Surprisingly, neuron-specific ATF4 inactivation did not alter EAE disease course or EAE-induced axon degeneration, neuron loss, and demyelination. These results suggest that PERK activation in neurons protects axons and neurons against inflammation in MS and EAE through ATF4-independent mechanisms.

Authors

Sarrabeth Stone, Yuan Yue, Milos Stanojlovic, Shuangchan Wu, Gerard Karsenty, Wensheng Lin

×

Figure 1

The PERK-mediated ISR was activated in neurons in the MOG-EAE model.

Options: View larger image (or click on image) Download as PowerPoint
The PERK-mediated ISR was activated in neurons in the MOG-EAE model.
(A ...
(A and B) Western blot analysis shows that the levels of ATF4, CHOP, and cleaved ATF6α were significantly increased in the brains of wild-type mice with EAE at the peak of disease (PID 19) compared with those in naive wild-type mice. (C) NeuN and p-eIF2α double immunostaining shows that the level of p-eIF2α was markedly increased in neurons in the layer V of the primary motor cortices of wild-type mice with EAE at the peak of disease (PID 19) compared with that in naive wild-type mice. (D) NeuN and CHOP double immunostaining shows the elevated level of CHOP and nuclear translocation of CHOP (arrows) in neurons in the layer V of the primary motor cortices of wild-type mice with EAE at the peak of disease (PID 19) compared with that in naive wild-type mice. Scale bars: 50 μm. n = 4 animals. Error bars represent SD. Statistical analyses were done with a 2-tailed t test, *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts